Role of the metabolites of arachidonate in platelet-dependent and independent experimental bronchoconstriction.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001095:Arachidonic Acids / Q000494:pharmacology*; D001241:Aspirin / Q000627:therapeutic use; D001792:Blood Platelets / Q000502:physiology*; D001986:Bronchial Spasm / Q000139:chemically induced / Q000188:drug therapy / Q000503:physiopathology*; D002351:Carrageenan / Q000009:adverse effects; D003094:Collagen / Q000009:adverse effects; D011464:Epoprostenol / Q000494:pharmacology; D006168:Guinea Pigs; D010974:Platelet Aggregation / Q000187:drug effects; D013189:SRS-A / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D001095:Arachidonic Acids; D013189:SRS-A; D002351:Carrageenan; D003094:Collagen; D011464:Epoprostenol; D001241:Aspirin